MEDXF - Medexus Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts1122
Avg. Estimate-0.05-0.09-0.290.03
Low estimate-0.05-0.09-0.33-0.1
High estimate-0.05-0.09-0.250.17
Year ago EPS-0.23-0.07-1.23-0.29
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts2222
Avg. Estimate28.3M27.21M107.74M116.44M
Low estimate28.3M26.9M107.71M112.3M
High estimate28.3M27.53M107.76M120.57M
Year ago sales20.26M23.05M76.7M107.74M
Sales growth (year/est)39.70%18.10%40.50%8.10%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.3-0.2-0.21-0.08
Actual EPS-0.23-0.07-0.14-0.07
Difference0.070.130.070.01
Surprise %23.30%65.00%33.30%12.50%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.05-0.09-0.290.03
7 days ago-0.05-0.09-0.290.03
30 days ago-0.05-0.09-0.290.03
60 days ago-0.090-0.37-0.1
90 days ago-0.090-0.37-0.1
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMEDXFIndustrySector(s)S&P 500
Current qtr.78.30%N/AN/AN/A
Next qtr.-28.60%N/AN/AN/A
Current year76.40%N/AN/AN/A
Next year110.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A